Related references
Note: Only part of the references are listed.Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease
Shuvadeep Maity et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease
Na Liu et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Dysregulation of the Basal Ganglia Indirect Pathway in Early Symptomatic Q175 Huntington's Disease Mice
Joshua W. Callahan et al.
JOURNAL OF NEUROSCIENCE (2022)
Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson's Symptoms
Palanisamy Sivanandy et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis
Daniel O. Claassen et al.
NEUROLOGY AND THERAPY (2022)
Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach
Seyede Nazanin Zarneshan et al.
PHARMACOLOGICAL RESEARCH (2022)
Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K/Akt/GSK-3β/Nrf2 signaling pathways in H2O2-treated PC-12 cells
Rui Han et al.
PHYTOMEDICINE (2022)
Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease
Claudia Bento-Pereira et al.
MEDICINAL RESEARCH REVIEWS (2021)
A dynamical model for the basal ganglia-thalamo-cortical oscillatory activity and its implications in Parkinson's disease
Eva M. Navarro-Lopez et al.
COGNITIVE NEURODYNAMICS (2021)
Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation
Bahattin Avci et al.
NEUROCHEMICAL RESEARCH (2021)
Inflaming the Brain with Iron
Pamela J. Urrutia et al.
ANTIOXIDANTS (2021)
Mitochondrial reactive oxygen species and heme, non-heme iron metabolism
Hiromu Ito et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease
Ji Won Choi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics
Luana Naia et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
Katrina Albert et al.
MOLECULAR THERAPY (2021)
Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson?s disease: The therapeutic role of Nrf2 activators
Saravanan Jayaram et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease
Hui-Zhi Long et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease
Jianhua Su et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model
Neha Sharma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins
Olga O. Gonchar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington?s disease
Ido Rippin et al.
NEUROBIOLOGY OF DISEASE (2021)
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Modeling Manifest Huntington's Disease Prevalence Using Diagnosed Incidence and Survival Time
Valerie Crowell et al.
NEUROEPIDEMIOLOGY (2021)
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
Efthalia Angelopoulou et al.
MOLECULAR NEUROBIOLOGY (2021)
Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
Akihiro Yamaguchi et al.
STEM CELL REPORTS (2020)
GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib
Junyu Li et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Neuroprotection Against Parkinson's Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A
Yanjun Huang et al.
FRONTIERS IN NEUROSCIENCE (2020)
Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders
Muhammad Ikram et al.
CELLS (2020)
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Angel Cores et al.
BIOMOLECULES (2020)
Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah A. Scuderi et al.
ANTIOXIDANTS (2020)
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019)
Carlos Roca et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi et al.
NATURE REVIEWS NEUROLOGY (2020)
Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1
Yuri Inose et al.
NEUROSCIENCE LETTERS (2020)
Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
Gueliz Armagan et al.
MOLECULES (2019)
Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives
Xing Huang et al.
MOLECULES (2019)
The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)
Francesca Morgante et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons
Yasuhiko Izumi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models
Huichun Tong et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Heme Oxygenase 1 in the Nervous System: Does It Favor Neuronal Cell Survival or Induce Neurodegeneration?
Mariapaola Nitti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A Mitochondria-Associated Oxidative Stress Perspective on Huntington's Disease
Ju Zheng et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Aqueous Extract of Davallia mariesii Attenuates 6-Hydroxydopamine-Induced Oxidative Damage and Apoptosis in B35 Cells Through Inhibition of Caspase Cascade and Activation of PI3K/AKT/GSK-3β Pathway
Chi-Rei Wu et al.
NUTRIENTS (2018)
Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions
Haidy E. Michel et al.
MOLECULAR NEUROBIOLOGY (2017)
Protective effect of Nrf2 ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model
Yuta Masaki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
3-NP-induced Huntington's-like disease impairs Nrf2 activation without loss of cardiac function in aged rats
A. Silva-Palacios et al.
EXPERIMENTAL GERONTOLOGY (2017)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease
Sara Moreira et al.
EXPERIMENTAL NEUROLOGY (2017)
Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways
Jagatheesan Nataraj et al.
NEUROCHEMICAL RESEARCH (2017)
DJ-1 regulating PI3K-Nrf2 signaling plays a significant role in bibenzyl compound 20C-mediated neuroprotection against rotenone-induced oxidative insult
Xiao-Ling Zhang et al.
TOXICOLOGY LETTERS (2017)
Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
Marta Pajares et al.
REDOX BIOLOGY (2017)
Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.
Aleksandra Milutinović et al.
Bosnian Journal of Basic Medical Sciences (2017)
Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway
Qunli Cui et al.
MOLECULAR MEDICINE REPORTS (2016)
Andrographolide protects liver cells from H2O2 induced cell death by upregulation of Nrf-2/HO-1 mediated via adenosine A2a receptor signalling
Smriti P. K. Mittal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions
F. L'Episcopo et al.
CELL DEATH & DISEASE (2016)
Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction
Limin Zhang et al.
PLOS ONE (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease
Yan Gao et al.
ACTA PHARMACOLOGICA SINICA (2015)
Structural basis of Keap1 interactions with Nrf2
Peter Canning et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
The emerging role of Nrf2 in mitochondrial function
Albena T. Dinkova-Kostova et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease
Marta Fernandez-Nogales et al.
HUMAN MOLECULAR GENETICS (2015)
NEUROPROTECTIVE EFFECT OF HEMEOXYGENASE-1/GLYCOGEN SYNTHASE KINASE-3β MODULATORS IN 3-NITROPROPIONIC ACID-INDUCED NEUROTOXICITY IN RATS
A. Khan et al.
NEUROSCIENCE (2015)
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich et al.
PHARMACOLOGICAL RESEARCH (2015)
The Role of Oxidative Stress in Neurodegenerative Diseases
Geon Ha Kim et al.
EXPERIMENTAL NEUROBIOLOGY (2015)
Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction
Adelheid Weidinger et al.
BIOMOLECULES (2015)
An association study between Heme oxygenase-1 genetic variants and Parkinson's disease
Pedro Ayuso et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
J. A. Morales-Garcia et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
Hemant Kumar et al.
CNS & Neurological Disorders-Drug Targets (2013)
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Orly Weinreb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity
Qing He et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes
Hong-Mei Wang et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease
Almas Siddiqui et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
NARINGIN MODULATES OXIDATIVE STRESS AND INFLAMMATION IN 3-NITROPROPIONIC ACID-INDUCED NEURODEGENERATION THROUGH THE ACTIVATION OF NUCLEAR FACTOR-ERYTHROID 2-RELATED FACTOR-2 SIGNALLING PATHWAY
K. Gopinath et al.
NEUROSCIENCE (2012)
GSK-3 and Wnt signaling in neurogenesis and bipolar disorder
Alexander J. Valvezan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease
J. Infante et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Nrf2 Regulates Microglial Dynamics and Neuroinflammation in Experimental Parkinson's Disease
Ana I. Rojo et al.
GLIA (2010)
Mutant Huntingtin and Glycogen Synthase Kinase 3-beta Accumulate in Neuronal Lipid Rafts of a Presymptomatic Knock-In Mouse Model of Huntington's Disease
Antonio Valencia et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
Nadia G. Innamorato et al.
PLOS ONE (2010)
Targeting Oxidative Stress for Neuroprotection
Daniel A. Linseman
ANTIOXIDANTS & REDOX SIGNALING (2009)
Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson's Disease
Joanne Clark et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Role of Glycogen Synthase Kinase-3β in Cardioprotection
Magdalena Juhaszova et al.
CIRCULATION RESEARCH (2009)
The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
Antonio Cuadrado et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Mitochondrial DNA damage and repair in neurodegenerative disorders
Jenq-Lin Yang et al.
DNA REPAIR (2008)
Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease
Xiaoming Hu et al.
JOURNAL OF IMMUNOLOGY (2008)
GSK-3β down-regulates the transcription factor Nrf2 after oxidant damage:: relevance to exposure of neuronal cells to oxidative stress
Ana I. Rojo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Glycogen synthase kinase-3β inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
Maria Salazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Astrocytes induce hemeoxygenase-1 expression in microglia: A feasible mechanism for preventing excessive brain inflammation
KJ Min et al.
JOURNAL OF NEUROSCIENCE (2006)
Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo
AY Shih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription
MJ Calkins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death
G Chen et al.
FASEB JOURNAL (2004)
The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress
T Nguyen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
H Hochstrasser et al.
NEUROLOGY (2004)
Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner
M Salinas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation
J Carmichael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
